Treatment of aplastic anemia with nandrolone decanoate.
D000293:Adolescent; D000328:Adult; D000741:Anemia, Aplastic / Q000139:chemically induced / Q000188:drug therapy* / Q000209:etiology; D000814:Aniline Compounds / Q000009:adverse effects; D001554:Benzene / Q000009:adverse effects; D001856:Bone Marrow Examination; D002648:Child; D002701:Chloramphenicol / Q000009:adverse effects; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009277:Nandrolone / Q000009:adverse effects / Q000627:therapeutic use*; D010578:Petroleum / Q000009:adverse effects; D010653:Phenylbutazone / Q000009:adverse effects; D014376:Tuberculosis / Q000150:complications; D014770:Virilism
D000814:Aniline Compounds; D010578:Petroleum; D002701:Chloramphenicol; D009277:Nandrolone; D010653:Phenylbutazone; D001554:Benzene